Literature DB >> 18541147

hnRNP G elicits tumor-suppressive activity in part by upregulating the expression of Txnip.

Ki-Hyuk Shin1, Reuben H Kim, Roy H Kim, Mo K Kang, No-Hee Park.   

Abstract

Heterogeneous nuclear ribonuclearproteins (hnRNPs) are nucleic acid-binding proteins and have critical roles in DNA repair, telomere regulation, and transcriptional gene regulation. Previously, we showed that hnRNP G has tumor-suppressive activity in human oral squamous cell carcinoma cells. Therefore, the identification of hnRNP G target genes is important for understanding the function of hnRNP G and its tumor-suppressive activity. In this study, we identify a known tumor suppressor gene, thioredoxin-interacting protein (Txnip) gene as a novel target of hnRNP G. Expression of Txnip is upregulated by wild-type (wt) hnRNP G but not by a suppression-defective mutant hnRNP G (K22R) in human squamous cell carcinoma. Wt hnRNP G binds and transactivates the Txnip promoter in vivo, whereas the K22R mutant does not. Furthermore, overexpression of Txnip alone in cancer cells leads to the inhibition of anchorage-independent growth and in vivo tumorigenicity in immunocompromised mice, suggesting a reversion of the transformation phenotype. These studies indicate that hnRNP G promotes the expression of Txnip and mediates its tumor-suppressive effect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541147      PMCID: PMC2519094          DOI: 10.1016/j.bbrc.2008.05.175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  hnRNP complexes: composition, structure, and function.

Authors:  A M Krecic; M S Swanson
Journal:  Curr Opin Cell Biol       Date:  1999-06       Impact factor: 8.382

2.  The candidate spermatogenesis gene RBMY has a homologue on the human X chromosome.

Authors:  M L Delbridge; P A Lingenfelter; C M Disteche; J A Graves
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

3.  Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis.

Authors:  Z Wang; Y P Rong; M H Malone; M C Davis; F Zhong; C W Distelhorst
Journal:  Oncogene       Date:  2006-03-23       Impact factor: 9.867

4.  Heterogeneous nuclear ribonucleoproteins: role in RNA splicing.

Authors:  Y D Choi; P J Grabowski; P A Sharp; G Dreyfuss
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

5.  Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.

Authors:  Jun-Ho Jeon; Kee-Nyung Lee; Chae Young Hwang; Ki-Sun Kwon; Kwan-Hee You; Inpyo Choi
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

6.  Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition.

Authors:  Sonal S Sheth; Lawrence W Castellani; Soumya Chari; Cory Wagg; Christopher K Thipphavong; Jackie S Bodnar; Peter Tontonoz; Alan D Attie; Gary D Lopaschuk; Aldons J Lusis
Journal:  J Lipid Res       Date:  2004-11-01       Impact factor: 5.922

7.  Heterogeneous nuclear ribonucleoprotein D0B is a sequence-specific DNA-binding protein.

Authors:  M Tolnay; L A Vereshchagina; G C Tsokos
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

8.  Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3.

Authors:  K S Chen; H F DeLuca
Journal:  Biochim Biophys Acta       Date:  1994-09-13

9.  A novel 43-kDa glycoprotein is detected in the nucleus of mammalian cells by autoantibodies from dogs with autoimmune disorders.

Authors:  M Soulard; J P Barque; V Della Valle; D Hernandez-Verdun; C Masson; F Danon; C J Larsen
Journal:  Exp Cell Res       Date:  1991-03       Impact factor: 3.905

10.  Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis.

Authors:  Yumiko Nishinaka; Akira Nishiyama; Hiroshi Masutani; Shin-ichi Oka; Kaimul Md Ahsan; Yukie Nakayama; Yasuyuki Ishii; Hajime Nakamura; Michiyuki Maeda; Junji Yodoi
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

View more
  19 in total

1.  Expression of RBMX in the light-induced damage of rat retina in vivo.

Authors:  Ming Dai; Yonghua Liu; Xiaoke Nie; Jinlong Zhang; Yong Wang; Jindong Ben; Su Zhang; Xiaowei Yang; Aimin Sang
Journal:  Cell Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.046

Review 2.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

3.  Expression and mutation analysis of heterogeneous nuclear ribonucleoprotein G in human oral cancer.

Authors:  Ki-Hyuk Shin; Reuben H Kim; Bo Yu; Mo K Kang; David Elashoff; Russell Christensen; Ana Pucar; No-Hee Park
Journal:  Oral Oncol       Date:  2011-08-12       Impact factor: 5.337

4.  Novel domains in the hnRNP G/RBMX protein with distinct roles in RNA binding and targeting nascent transcripts.

Authors:  Rasha Kanhoush; Brent Beenders; Caroline Perrin; Jacques Moreau; Michel Bellini; May Penrad-Mobayed
Journal:  Nucleus       Date:  2010 Jan-Feb       Impact factor: 4.197

Review 5.  The emerging role of the thioredoxin system in angiogenesis.

Authors:  Louise L Dunn; Andrew M Buckle; John P Cooke; Martin K C Ng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-26       Impact factor: 8.311

6.  Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.

Authors:  Chang-Ryul Lee; Sung Hee Lee; Nicole Kristina Rigas; Reuben H Kim; Mo K Kang; No-Hee Park; Ki-Hyuk Shin
Journal:  Carcinogenesis       Date:  2015-12-08       Impact factor: 4.944

7.  Expression of RBMX after spinal cord injury in rats.

Authors:  Jinlong Zhang; Debao Li; Aiguo Shen; Hui Mao; Huricha Jin; Wei Huang; Dawei Xu; Jianbo Fan; Jiajia Chen; Longfei Yang; Zhiming Cui
Journal:  J Mol Neurosci       Date:  2012-11-22       Impact factor: 3.444

8.  The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein.

Authors:  Jungwon Hwang; Hyun-Woo Suh; Young Ho Jeon; Eunha Hwang; Loi T Nguyen; Jeonghun Yeom; Seung-Goo Lee; Cheolju Lee; Kyung Jin Kim; Beom Sik Kang; Jin-Ok Jeong; Tae-Kwang Oh; Inpyo Choi; Jie-Oh Lee; Myung Hee Kim
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

9.  Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer.

Authors:  Jennifer A Morrison; Laura A Pike; Sharon B Sams; Vibha Sharma; Qiong Zhou; Jill J Severson; Aik-Choon Tan; William M Wood; Bryan R Haugen
Journal:  Mol Cancer       Date:  2014-03-19       Impact factor: 27.401

10.  Characterization of the RNA recognition mode of hnRNP G extends its role in SMN2 splicing regulation.

Authors:  Ahmed Moursy; Frédéric H-T Allain; Antoine Cléry
Journal:  Nucleic Acids Res       Date:  2014-04-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.